CTN Bulletin logo
March 24, 2017   

NIDA Good Clinical Practice Training Site Updated



The NIDA Clinical Coordinating Center is pleased to announce that the CTN's Good Clinical Practice training website at has been up-versioned as of March 3, 2017.

The new GCP website offers a number of enhancements:

  • Instructional material based on the amended ICH GCP Principles (Nov 2016).
  • Highly engaging and relevant e-learning interactions have been incorporated throughout the course to improve the learner's ability to understand and retain the instructional material.
  • Streamlined content to enhance accessibility.
  • Modified quiz questions to help learners demonstrate retained knowledge.
  • CTN-focused content is available throughout the course for network members.

Since its inception in 2005, the course has been a success, with the user base growing from less than 100 users in the first year to over 30,000 in early 2017. In the last year (from Feb 2016 to Jan 2017), over 38,000 GCP certificates were issued.

We encourage CTN members to visit the new site at http://gcp.nidatraining.org to complete your training and for renewal. As a reminder, NIH requires completion of the course every 3 years.

For questions or comments, please contact us at CTNtraining@emmes.com.

CTN Trial Progress

GraphStudy results for Open Studies as of the March 22 trial Progress Report.

CTN-0050 - Long Term Follow-up to CTN-0027: Enrolled 877 (original N=1,267 START Study participants)

CTN-0051 - X-BOT (Extended Release Naltrexone vs. Buprenorphine for Opioid Treatment). Enrolled 570

CTN-0051-A2 - Detoxification TAU. Enrolled 211

CTN-0056-Ot - Testing and Linkage to HIV Care in China. Enrolled 478

CTN-0064 - Linkage to HCV Care. Enrolled 113

Total Enrolled in all Studies: 24,219

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

journal coversNew from the CTN Dissemination Library

Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network. Kidd JD, et al. Substance Use & Misuse 2017 (in press). Get article. . .

Acceptability and Effectiveness of a Web-Based Psychosocial Intervention Among Criminal Justice Involved Adults. Lee JD, et al. Health & Justice 2017 (in press). Get article. . .

Chronic Pain Among Patients with Opioid Use Disorder: Results from Electronic Health Records Data. Hser Y, et al. Journal of Substance Abuse Treatment 2017 (in press). Get article. . .

The Effect of Partly Missing Covariates on Statistical Power in Randomized Controlled Trials with Discrete-Time Survival Endpoints. Jolani S & Safarkhani M. Methodology 2017 (in press). Get article. . .

Efficacy of Motivational Enhancement Therapy to Decrease Alcohol and Illicit-Drug Use in Pregnant Substance Users Reporting Baseline Alcohol Use. Osterman R, et al. Journal of Substance Abuse Treatment 2017 (in press). Get article. . .

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

Northeast Node

A growing line of research has highlighted the promising role that interactive technologies (e.g., web, mobile devices) may play in the assessment, prevention, treatment, and recovery management of substance use disorders.

Lisa Marsch, PhD, Principal Investigator of the CTN Northeast Node and Director of the Dartmouth Center for Technology and Behavioral Health, presented on Harnessing Digital Technologies in the Treatment of Substance Use Disorders for the Northeast Node's Science Series on January 26, 2017.

Dr. Marsch provided an overview of the state of the science in the development, evaluation, and implementation of technology-based therapeutic interventions for substance use disorders. This research underscores the role that technology may play in improving treatment for substance use disorders in a manner that increases access to care, is cost-effective, ensures fidelity, and enables the rapid diffusion and widespread adoption of science-based interventions. This presentation can be viewed at the Node's Science Series site.

The node is pleased to announce the next presentation in the series, entitle The Voices of New Hampshire Young Adults. On March 30, 2017, Jill Burke, MPA, Katy Shea, MPH, and Rachel Kohn, MSW, MPH will present on a project conducted by the New Hampshire Bureau of Drug and Alcohol Services and its contracted evaluation entity, the NH Center of Excellence, on an assessment of young adults' risk perception, behaviors, and attitudes related to binge drinking and the non-medical use of prescription drugs including opioids and illicit opioids.

The team employed a mixed methodology of both focus groups and an online survey. In total, the team conducted 57 focus groups with 366 participants in the State. The presentation will focus on the key themes that emerged and their implications for prevention programming. For more information or to access the presentation, please visit the Science Series site. You can find the full report here.

Follow the Northeast Node on Twitter and Facebook for updates!

Southern Consortium Node

Building on a long, successful history of collaboration, Dr. Kathleen Brady and members of the Southern Consortium Node are partnering with the South Carolina Single State Authority (SCDAODAS) to expand medication-assisted treatment for opioid use disorder services across the state.

The Medical University of South Carolina initiative will include developing a resource website, expanding the use of the MUSC Center for Telehealth, academic detailing, expansion of the SBIRT program, and the implementation of the Project ECHO model.


Pacific Northwest Node

The Pacific Northwest Node is excited to announce that one of our CTP directors, Molly Carney, of Evergreen Treatment Services, will be receiving the Excellence in Advocacy - Individual Achievement award at the National Council for Behavioral Health meeting this April in Seattle!

The National Council for Behavioral Health is the unifying voice of America's mental health and addictions treatment organizations. Its annual Awards of Excellence honor the advocates and leaders advancing public policies that support improved quality of and access to care, organizations that promote excellence and build health communities, and the achievements of individuals with mental illnesses and addictions, their family members, and the professionals who care for them.

Molly Carney, PhD, MBA is trained as a clinical psychologist and has worked in substance use disorder treatment since 1986, most recently as director of Evergreen Treatment Services, a private, nonprofit agency offering medication-assisted treatment for adults with opioid use disorders since 1973.

The Pacific Northwest Node says "Congratulations and thank you for your outstanding service!" to Dr. Carney!

Ohio Valley Node

Ohio Valley Pediatrics Team to Present on Underinsurance
Dr. John Pascoe (Rocking Horse Center; OVN) and colleagues will be sharing an abstract on pediatric underinsurance at the Pediatric Academic Societies Annual Meeting on May 7, 2017 in San Francisco. The abstract summarizes data analysis on over 1100 families from clinical sites in the Southwestern Ohio Ambulatory Research Network (SOAR-Net). In summary, the analysis found that all children included in study had health insurance, but one in 7 parents reported they could not follow doctors’ recommendations for their child(ren) because they couldn’t afford the medicine/service in the past 12 months. Congratulations to Dr. Pascoe and colleagues on being accepted to share this important information!

Ohio Valley Researchers Perform NIDA-Funded Study on Opioid Overdose Prevention
Dr. Theresa Winhusen (Ohio Valley Node PI; University of Cincinnati) has teamed up with Dr. Michael Lyons’ team at the University of Cincinnati (UC) Department of Emergency Medicine to perform a NIDA-funded study on preventing further opioid overdoses with patients presenting at the UC Medical Center Emergency Department for current opioid overdose. The study investigates the impact of a peer-delivered phone intervention (TTIP-PRO) aimed at 1) increasing knowledge about opioid overdose prevention, 2) dispelling myths about medication-assisted treatment (MAT), and 3) encouraging participants to enter MAT services.



Published by the CTN Dissemination Library of the Pacific Northwest Node
Alcohol & Drug Abuse Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol & Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe

Copyright (C) 2016 Alcohol and Drug Abuse Institute. All rights reserved.